Financials Marker Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 11/03/2026 GMT			5-day change	1st Jan Change
1.370 ^USD	-2.84%		0.00%	-8.05%

11-14	Marker Therapeutics Q3 net loss narrows to $2 mln	RE
11-13	Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	0.4668	1.242	9.014	-	6.591	3.097	2.695	19.49
Change	-	166.01%	625.9%	-	-	-53.02%	-12.97%	623.03%
EBITDA ¹	-	-	-	-	-11.12	-14.39	-16.66	-15.99
Change	-	-	-	-	-	-29.43%	-15.76%	4%
EBIT ¹	-28.89	-39.48	-	-	-11.12	-14.63	-24.27	-22.33
Change	-	-36.67%	-	-	-	-31.56%	-65.94%	8.01%
Interest Paid	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-28.71	-41.88	-	-14.04	-10.68	-13.77	-23.94	-22.33
Change	-	-45.89%	-	-	23.93%	-28.93%	-73.87%	6.73%
Net income ¹	-28.71	-41.88	-	-8.237	-10.73	-13.8	-24.04	-19.93
Change	-	-45.89%	-	-	-30.28%	-28.64%	-74.18%	17.1%
Announcement Date	09/03/21	17/03/22	22/03/23	25/03/24	31/03/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	-	-	-	1.242	0.9643	0.7905	3.95	3.309	1.244	1.169	1.926	2.252	0.3491	0.8612	1.233	0.682	0.6	0.6	0.6	0.6
Change	-	-	-	-	-	-22.34%	-18.02%	399.62%	-16.22%	-62.41%	-6.01%	64.72%	16.91%	-84.5%	146.69%	43.17%	-44.69%	-12.02%	0%	0%	0%
EBITDA ¹	-	-	-	-	-	-	-	-	-	-	-	-	-3.861	-	-4.261	-2.137	-3.388	-4.1	-5.1	-5.2	-5.4
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49.85%	-58.56%	-21.02%	-24.39%	-1.96%	-3.85%
EBIT ¹	-8.508	-8.781	-10.91	-10.02	-9.764	-9.795	-9.28	-7.019	-	-2.549	-2.308	-2.4	-3.861	-4.609	-4.261	-2.137	-3.625	-4.1	-5.1	-5.2	-5.4
Change	-	-3.2%	-24.24%	8.12%	2.59%	-0.31%	5.26%	24.36%	-	-	9.45%	-3.98%	-60.9%	-19.35%	7.54%	49.85%	-69.67%	-13.09%	-24.39%	-1.96%	-3.85%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-8.507	-8.779	-10.91	-12.43	-9.763	-9.911	-9.244	-6.92	-	-2.393	-2.308	-2.308	-3.788	-4.446	-4.016	-1.999	-3.285	-3.9	-4.9	-5	-5.2
Change	-	-3.2%	-24.23%	-13.96%	21.45%	-1.51%	6.72%	25.15%	-	-	3.54%	-0.01%	-64.1%	-17.39%	9.69%	50.23%	-64.36%	-18.72%	-25.64%	-2.04%	-4%
Net income ¹	-8.507	-8.779	-10.91	-12.43	-9.763	-9.911	-9.244	-6.92	-	-2.393	-2.193	-2.308	-3.838	-4.446	-4.016	-1.999	-3.318	-3.9	-4.9	-5	-5.2
Change	-	-3.2%	-24.23%	-13.96%	21.45%	-1.51%	6.72%	25.15%	-	-	8.36%	-5.27%	-66.26%	-15.86%	9.69%	50.23%	-66.03%	-17.53%	-25.64%	-2.04%	-4%
Announcement Date	09/03/21	12/05/21	10/08/21	10/11/21	17/03/22	13/05/22	11/08/22	10/11/22	22/03/23	15/05/24	14/08/24	14/11/24	31/03/25	15/05/25	14/08/25	13/11/25	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	09/03/21	17/03/22	22/03/23	25/03/24	31/03/25	-	-	-

Estimates

Fiscal Period: December	2021	2025	2026	2027
CAPEX ¹	-	-	-	-
Change	-	-	-	-
Free Cash Flow (FCF) ¹	-30.41	-10.5	-13	-18.7
Change	-	-	-23.81%	-43.85%
Announcement Date	17/03/22	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-168.69%	-464.73%	-618.16%	-82.08%
EBIT Margin (%)	-6,188.18%	-3,179.33%	-	-	-168.69%	-472.36%	-900.67%	-114.59%
EBT Margin (%)	-6,149.68%	-3,372.68%	-	-	-162.06%	-444.73%	-888.5%	-114.62%
Net margin (%)	-6,149.68%	-3,372.68%	-	-	-162.82%	-445.8%	-892.21%	-102.3%
FCF margin (%)	-	-2,449.11%	-	-	-	-339.07%	-482.37%	-95.97%
FCF / Net Income (%)	-	72.62%	-	-	-	76.06%	54.07%	93.81%
Profitability
ROA	-	-	-	-	-	-71.4%	-131.3%	-55%
ROE	-	-	-	-	-	-76.1%	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-0.63	-2.06	-1.47
Change	-	-	-	-	-	-	-226.98%	28.64%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EPS ¹	-6.1	-5.5	-3.58	-	-1.19	-0.9433	-1.44	-0.9533
Change	-	9.84%	34.91%	-	-	20.73%	-52.65%	33.8%
Nbr of stocks (in thousands)	4,803	8,308	8,540	-	10,707	16,673	16,673	16,673
Announcement Date	09/03/21	17/03/22	22/03/23	-	31/03/25	-	-	-